Hydration and nourishment are key
(Exenatide is FDA approved as monotherapy for the management of T2DM.) Explicitly stated in the guideline for patients requiring dual or triple therapy, the AACE/ACE preferentially recommends the addition of a GLP-1 receptor agonist or a DPP-4 inhibitor (sitagliptin, saxagliptin), citing their efficacy and safety profiles as preferred agents over TZDs or sulfonylureas (SUs)
Victoria Falcone has been a liposuction specialist since 2007
Whether it's the protein-packed Get Fit Blends, the nutrient-dense Be Well Blends, or the lower calorie Manage Weight Blends, every option is made with real, whole ingredients to help customers achieve their health and wellness goals
Growth hormone promotes lymphangiogenesis
Understanding these differences is essential for patients and healthcare providers when making informed treatment decisions